Objective: Measurement of brachial cuff blood pressure (BP) was designed as a convenient surrogate to the aortic BP, which is the BP that dictates perfusion to target organs. In the general population, brachial cuff systolic BP (SBP) has a somewhat acceptable accuracy towards aortic BP but less is know in populations with marked high arterial stiffness, such as in G4-G5 CKD. Central BP devices were designed to directly estimate the aortic BP through pulse wave analysis to a greater accuracy than brachial cuff BP. The aim of the ongoing VALIDATE-CKD study is to compare the accuracy of brachial and central BP readings towards the intraarterial aortic SBP, in patients with and without Stage G4-G5 CKD. Design and method: In patients with and without Stage G4-G5 CKD (eGFR < 30 ml/min/1.73m2) undergoing non-urgent coronary angiograms, invasive aortic and non-invasive (WatchBP and Mobil-o-graph devices) BPs were measured simultaneously following the ARTERY Society protocol. Accuracy was defined by the mean difference (± SD) between the aortic SBP and the corresponding non-invasive SBP. Results: To date, 8 individuals with Stage G4-G5 CKD and 26 control subjects are enrolled. The following table presents clinical characteristics and non-invasive BPs accuracies in patients with and without Stage G4-G5 CKD. Conclusion: These preliminary results indicate that brachial SBP significantly underestimates aortic SBP in patients with Stage G4-5 CKD as compared to control subject. Furthermore, central BP devices provide a highly accurate estimation of aortic SBP in this population. The ongoing VALIDATE-CKD study may support that the use of central BP devices could be beneficial for the management of patients with advanced CKD.